Skip to main content
SpringerLink
Log in

Extra-intestinal Manifestations

  • Chapter
  • First Online:
Inflammatory Bowel Disease Nursing Manual

Abstract

Extra-intestinal manifestations (EIM) affect up to 50% of the patients with inflammatory bowel disease. The most classical EIM are spondyloarthritis, skin lesions like erythema nodosum and pyoderma gangrenosum, eye inflammation with episcleritis, scleritis and uveitis, and also primary sclerosing cholangitis. These manifestations will classically present as axial or peripheral arthralgias or arthritis, inflammatory lesions of the skin, a red inflammatory eye or abnormal liver function tests. EIMs may evolve in parallel or independently from the gastrointestinal inflammation. Some of them may require specific management and treatment. More seldom manifestation may also affect most organs of the body and can be the consequence of chronic systemic inflammation or due to shared genetic or environmental predisposing factors.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 79.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 99.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  • Bermejo F, Lopez-Sanroman A, Taxonera C et al (2008) Acute pancreatitis in inflammatory bowel disease, with special reference to azathioprine-induced pancreatitis. Aliment Pharmacol Ther 28:623–628

    Article  CAS  Google Scholar 

  • Bernstein CN, Blanchard JF, Rawsthorne P et al (2001) The prevalence of extraintestinal diseases in inflammatory bowel disease: a population-based study. Am J Gastroenterol 96:1116–1122

    Article  CAS  Google Scholar 

  • Bjornsson E, Olsson R, Bergquist A et al (2008) The natural history of small-duct primary sclerosing cholangitis. Gastroenterology 134:975–980

    Article  Google Scholar 

  • Black H, Mendoza M, Murin S (2007) Thoracic manifestations of inflammatory bowel disease. Chest 131:524–532

    Article  Google Scholar 

  • Bonniere P, Wallaert B, Cortot A et al (1986) Latent pulmonary involvement in Crohn’s disease: biological, functional, bronchoalveolar lavage and scintigraphic studies. Gut 27:919–925

    Article  CAS  Google Scholar 

  • Braun J, van den Berg R, Baraliakos X et al (2011) 2010 update of the ASAS/EULAR recommendations for the management of ankylosing spondylitis. Ann Rheum Dis 70:896–904

    Article  CAS  Google Scholar 

  • Brooklyn T, Dunnill G, Probert C (2006) Diagnosis and treatment of pyoderma gangrenosum. BMJ 333:181–184

    Article  Google Scholar 

  • Chen J, Lin S, Liu C (2014) Sulfasalazine for ankylosing spondylitis. Cochrane Database Syst Rev 11:CD004800

    Google Scholar 

  • Cleynen I, Vermeire S (2012) Paradoxical inflammation induced by anti-TNF agents in patients with IBD. Nat Rev Gastroenterol Hepatol 9:496–503

    Article  CAS  Google Scholar 

  • El Miedany Y, Youssef S, Ahmed I et al (2006) The gastrointestinal safety and effect on disease activity of etoricoxib, a selective cox-2 inhibitor in inflammatory bowel diseases. Am J Gastroenterol 101:311–317

    Article  Google Scholar 

  • Ernst BB, Lowder CY, Meisler DM et al (1991) Posterior segment manifestations of inflammatory bowel disease. Ophthalmology 98:1272–1280

    Article  CAS  Google Scholar 

  • Farhi D, Cosnes J, Zizi N et al (2008) Significance of erythema nodosum and pyoderma gangrenosum in inflammatory bowel diseases: a cohort study of 2402 patients. Medicine (Baltimore) 87:281–293

    Article  Google Scholar 

  • Felder JB, Korelitz BI, Rajapakse R et al (2000) Effects of nonsteroidal antiinflammatory drugs on inflammatory bowel disease: a case-control study. Am J Gastroenterol 95:1949–1954

    Article  CAS  Google Scholar 

  • Fornaciari G, Salvarani C, Beltrami M et al (2001) Musculoskeletal manifestations in inflammatory bowel disease. J Clin Gastroenterol. 15:399–403

    CAS  Google Scholar 

  • Fumery M, Xiaocang C, Dauchet L et al (2014) Thromboembolic events and cardiovascular mortality in inflammatory bowel diseases: a meta-analysis of observational studies. J Crohns Colitis 8:469–479

    Article  Google Scholar 

  • Gisbert JP, Gonzalez-Lama Y, Mate J (2007) 5-Aminosalicylates and renal function in inflammatory bowel disease: a systematic review. Inflamm Bowel Dis 13:629–638

    Article  Google Scholar 

  • Gondim FA, Brannagan TH 3rd, Sander HW et al (2005) Peripheral neuropathy in patients with inflammatory bowel disease. Brain 128:867–879

    Article  CAS  Google Scholar 

  • Greenstein AJ, Sachar DB, Panday AK et al (1992) Amyloidosis and inflammatory bowel disease. A 50-year experience with 25 patients. Medicine (Baltimore) 71:261–270

    Article  CAS  Google Scholar 

  • Gupta G, Gelfand JM, Lewis JD (2005) Increased risk for demyelinating diseases in patients with inflammatory bowel disease. Gastroenterology 129:819–826

    Article  Google Scholar 

  • Harbord M, Annese V, Vavricka S et al (2016) The First European evidence-based consensus on extra-intestinal manifestations in inflammatory bowel disease. J Crohns Colitis 3:239–254

    Article  Google Scholar 

  • Hatoum OA, Spinelli KS, Abu-Hajir M et al (2005) Mesenteric venous thrombosis in inflammatory bowel disease. J Clin Gastroenterol 39:27–31

    PubMed  Google Scholar 

  • Heikius B, Niemela S, Lehtola J et al (1996) Pancreatic duct abnormalities and pancreatic function in patients with chronic inflammatory bowel disease. Scand J Gastroenterol 31:517–523

    Article  CAS  Google Scholar 

  • Hindorf U, Johansson M, Eriksson A et al (2009) Mercaptopurine treatment should be considered in azathioprine intolerant patients with inflammatory bowel disease. Aliment Pharmacol Ther 29:654–661

    Article  CAS  Google Scholar 

  • Karlsen TH, Schrumpf E, Boberg KM (2010) Update on primary sclerosing cholangitis. Dig Liver Dis 42:390–400

    Article  CAS  Google Scholar 

  • Khokhar OS, Lewis JH (2010) Hepatotoxicity of agents used in the management of inflammatory bowel disease. Dig Dis 28:508–518

    Article  Google Scholar 

  • Kristensen SL, Ahlehoff O, Lindhardsen J et al (2013) Disease activity in inflammatory bowel disease is associated with increased risk of myocardial infarction, stroke and cardiovascular death--a Danish nationwide cohort study. PLoS One 8:e56944

    Article  CAS  Google Scholar 

  • Larsen S, Bendtzen K, Nielsen OH (2010) Extraintestinal manifestations of inflammatory bowel disease: epidemiology, diagnosis, and management. Ann Med 42:97–114

    Article  Google Scholar 

  • Levy-Clarke G, Jabs DA, Read RW et al (2014) Expert panel recommendations for the use of anti-tumor necrosis factor biologic agents in patients with ocular inflammatory disorders. Ophthalmology 121:785–796 e3

    Article  Google Scholar 

  • Lewis B, Mukewar S, Lopez R et al (2013) Frequency and risk factors of renal insufficiency in inflammatory bowel disease inpatients. Inflamm Bowel Dis 19:1846–1851

    Article  Google Scholar 

  • Lyons JL, Rosenbaum JT (1997) Uveitis associated with inflammatory bowel disease compared with uveitis associated with spondyloarthropathy. Arch Ophthalmol 115:61–64

    Article  CAS  Google Scholar 

  • McCluggage WG, Sloan JM (1994) Hepatic granulomas in Northern Ireland: a thirteen year review. Histopathology 25:219–228

    Article  CAS  Google Scholar 

  • Mintz R, Feller ER, Bahr RL et al (2004) Ocular manifestations of inflammatory bowel disease. Inflamm Bowel Dis 10:135–139

    Article  Google Scholar 

  • Mir-Madjlessi SH, McHenry MC, Farmer RG (1986) Liver abscess in Crohn’s disease. Report of four cases and review of the literature. Gastroenterology 91:987–993

    Article  CAS  Google Scholar 

  • Mowat C, Cole A, Windsor A et al (2011) Guidelines for the management of inflammatory bowel disease in adults. Gut 60:571–607

    Article  Google Scholar 

  • Orchard TR, Wordsworth BP, Jewell DP (1998) Peripheral arthropathies in inflammatory bowel disease: their articular distribution and natural history. Gut 42:387–391

    Article  CAS  Google Scholar 

  • Orchard TR, Holt H, Bradbury L et al (2009) The prevalence, clinical features and association of HLA-B27 in sacroiliitis associated with established Crohn’s disease. Aliment Pharmacol Ther 29:193–197

    Article  CAS  Google Scholar 

  • Palm O, Moum B, Ongre A et al (2002) Prevalence of ankylosing spondylitis and other spondyloarthropathies among patients with inflammatory bowel disease: a population study (the IBSEN study). J Rheumatol 29:511–515

    PubMed  Google Scholar 

  • Polcz M, Gu J, Florin T (2011) Pyoderma gangrenosum in inflammatory bowel disease: the experience at Mater Health Services’ Adult Hospital 1998-2009. J Crohns Colitis 5:148–151

    Article  Google Scholar 

  • Reinshagen M (2008) Osteoporosis in inflammatory bowel disease. J Crohns Colitis 2:202–207

    Article  Google Scholar 

  • Salvarani C, Vlachonikolis IG, van der Heijde DM et al (2001) Musculoskeletal manifestations in a population-based cohort of inflammatory bowel disease patients. Scand J Gastroenterol 36:1307–1313

    Article  CAS  Google Scholar 

  • Sen HN, Sangave AA, Goldstein DA et al (2011) A standardized grading system for scleritis. Ophthalmology 118:768–771

    Article  Google Scholar 

  • Singh S, Singh H, Loftus EV Jr et al (2014) Risk of cerebrovascular accidents and ischemic heart disease in patients with inflammatory bowel disease: a systematic review and meta-analysis. Clin Gastroenterol Hepatol 12:382–93 e1 quiz e22

    Article  Google Scholar 

  • Travis S, Innes N, Davies MG et al (1997) Sweet’s syndrome: an unusual cutaneous feature of Crohn’s disease or ulcerative colitis. The South West Gastroenterology Group. Eur J Gastroenterol Hepatol 9:715–720

    Article  CAS  Google Scholar 

  • Trivedi PJ, Chapman RW (2012) PSC, AIH and overlap syndrome in inflammatory bowel disease. Clin Res Hepatol Gastroenterol 36:420–436

    Article  CAS  Google Scholar 

  • Trost LB, McDonnell JK (2005) Important cutaneous manifestations of inflammatory bowel disease. Postgrad Med J 81:580–585

    Article  CAS  Google Scholar 

  • Van Assche G, Dignass A, Bokemeyer B et al (2013) Second European evidence-based consensus on the diagnosis and management of ulcerative colitis part 3: special situations. J Crohns Colitis 7:1–33

    Article  Google Scholar 

  • Van den Bosch F, Kruithof E, De Vos M et al (2000) Crohn’s disease associated with spondyloarthropathy: effect of TNF-alpha blockade with infliximab on articular symptoms. Lancet 356:1821–1822

    Article  Google Scholar 

  • Yuhara H, Steinmaus C, Corley D et al (2013) Meta-analysis: the risk of venous thromboembolism in patients with inflammatory bowel disease. Aliment Pharmacol Ther 37:953–962

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Gastroenterology Department, Liège University Hospital CHU, Liège, Belgium

    N. Chapelier, I. Dury & E. Louis

Authors
  1. N. Chapelier
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. I. Dury
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. E. Louis
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to E. Louis .

Editor information

Editors and Affiliations

  1. DRK Kliniken Berlin Westend, Department of Gastroenterology, Berlin, Germany

    Andreas Sturm

  2. Gastroenterology Level 5, John Radcliffe Hospital, Oxford, UK

    Lydia White

Rights and permissions

Reprints and permissions

Copyright information

© 2019 Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Chapelier, N., Dury, I., Louis, E. (2019). Extra-intestinal Manifestations. In: Sturm, A., White, L. (eds) Inflammatory Bowel Disease Nursing Manual. Springer, Cham. https://doi.org/10.1007/978-3-319-75022-4_19

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-75022-4_19

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-75021-7

  • Online ISBN: 978-3-319-75022-4

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation